| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $79.7M | -12.0% |
| Cost of Revenue | $59.5M | -14.6% |
| Gross Profit | $20.2M | -3.2% |
| R&D Expense | $1.2M | -17.8% |
| SG&A Expense | $18.0M | +7.6% |
| Operating Income | -$10.6M | +2.1% |
| Pre-tax Income | -$11.8M | -1.1% |
| Income Tax | $42K | +2.4% |
| Net Income | -$11.8M |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.0M | +15.8% |
| Accounts Receivable | $12.8M | -8.4% |
| Inventory | $11.4M | -37.6% |
| Current Assets | $35.5M | -20.8% |
| Total Assets | $52.5M | -16.9% |
| Current Liabilities | $26.8M | -4.3% |
| Long-term Debt | $10.3M | +3.2% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $599K | +105.9% |
| Capital Expenditures | $99K | -88.2% |
| Investing Cash Flow | $128K | +117.5% |
| Financing Cash Flow | $90K | +742.9% |
| Free Cash Flow | $500K | +104.6% |
| -1.1% |
| EPS (Basic) | -$0.36 | +0.0% |
| EPS (Diluted) | -$0.36 | +0.0% |
| Total Liabilities |
| $40.6M |
| -0.1% |
| Stockholders' Equity | $11.9M | -47.3% |